96 related articles for article (PubMed ID: 8980646)
1. The inhibition of human factor Xa by plasminogen activator inhibitor type 1 in the presence of calcium ion, and its enhancement by heparin and vitronectin.
Urano T; Ihara H; Takada Y; Nagai N; Takada A
Biochim Biophys Acta; 1996 Dec; 1298(2):199-208. PubMed ID: 8980646
[TBL] [Abstract][Full Text] [Related]
2. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
Nakamura R; Umemura K; Hashimmoto H; Urano T
Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
[TBL] [Abstract][Full Text] [Related]
3. Coagulation-associated enhancement of fibrinolytic activity via a neutralization of PAI-1 activity.
Urano T; Ihara H; Suzuki Y; Takada Y; Takada A
Semin Thromb Hemost; 2000; 26(1):39-42. PubMed ID: 10805280
[TBL] [Abstract][Full Text] [Related]
4. On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site.
Keijer J; Linders M; Wegman JJ; Ehrlich HJ; Mertens K; Pannekoek H
Blood; 1991 Sep; 78(5):1254-61. PubMed ID: 1715220
[TBL] [Abstract][Full Text] [Related]
5. Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.
Urano T; Nagai N; Matsuura M; Ihara H; Takada Y; Takada A
Thromb Haemost; 1998 Jul; 80(1):161-6. PubMed ID: 9684803
[TBL] [Abstract][Full Text] [Related]
6. Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors.
Rezaie AR
Biochemistry; 1999 Nov; 38(44):14592-9. PubMed ID: 10545182
[TBL] [Abstract][Full Text] [Related]
7. Specific glycosaminoglycans support the inhibition of thrombin by plasminogen activator inhibitor 1.
Gebbink RK; Reynolds CH; Tollefsen DM; Mertens K; Pannekoek H
Biochemistry; 1993 Feb; 32(6):1675-80. PubMed ID: 8431448
[TBL] [Abstract][Full Text] [Related]
8. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.
Ehrlich HJ; Gebbink RK; Keijer J; Linders M; Preissner KT; Pannekoek H
J Biol Chem; 1990 Aug; 265(22):13029-35. PubMed ID: 1695900
[TBL] [Abstract][Full Text] [Related]
9. Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin.
Patston PA; Schapira M
Blood; 1994 Aug; 84(4):1164-72. PubMed ID: 8049432
[TBL] [Abstract][Full Text] [Related]
10. Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site.
Enjyoji K; Miyata T; Kamikubo Y; Kato H
Biochemistry; 1995 May; 34(17):5725-35. PubMed ID: 7727433
[TBL] [Abstract][Full Text] [Related]
11. The suicide substrate reaction between plasminogen activator inhibitor 1 and thrombin is regulated by the cofactors vitronectin and heparin.
van Meijer M; Smilde A; Tans G; Nesheim ME; Pannekoek H; Horrevoets AJ
Blood; 1997 Sep; 90(5):1874-82. PubMed ID: 9292520
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of inactivation of alpha-thrombin by plasminogen activator inhibitor-1. Comparison of the effects of native and urea-treated forms of vitronectin.
Naski MC; Lawrence DA; Mosher DF; Podor TJ; Ginsburg D
J Biol Chem; 1993 Jun; 268(17):12367-72. PubMed ID: 7685341
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a).
Edelberg JM; Reilly CF; Pizzo SV
J Biol Chem; 1991 Apr; 266(12):7488-93. PubMed ID: 1708387
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.
Sen P; Komissarov AA; Florova G; Idell S; Pendurthi UR; Vijaya Mohan Rao L
J Thromb Haemost; 2011 Mar; 9(3):531-9. PubMed ID: 21143380
[TBL] [Abstract][Full Text] [Related]
15. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
Wang Q; Shaltiel S
BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892
[TBL] [Abstract][Full Text] [Related]
16. Heparin and heparan sulfate enhancement of the inhibitory activity of plasminogen activator inhibitor type 1 toward urokinase type plasminogen activator.
Urano T; Serizawa K; Takada Y; Ny T; Takada A
Biochim Biophys Acta; 1994 Nov; 1201(2):217-22. PubMed ID: 7947934
[TBL] [Abstract][Full Text] [Related]
17. Effect of type-1 plasminogen activator inhibitor on human leukocyte elastase.
Abe H; Matsuda E; Binder BR
Thromb Res; 1994 Mar; 73(6):361-9. PubMed ID: 7521069
[TBL] [Abstract][Full Text] [Related]
18. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
Ehrlich HJ; Gebbink RK; Preissner KT; Keijer J; Esmon NL; Mertens K; Pannekoek H
J Cell Biol; 1991 Dec; 115(6):1773-81. PubMed ID: 1721912
[TBL] [Abstract][Full Text] [Related]
19. Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C.
Rezaie AR
J Biol Chem; 2001 May; 276(19):15567-70. PubMed ID: 11264280
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
